Clinical Trial Update: Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety study of AEM-28 for refractory hypercholesterolemia completed; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• AEM-28

Snippet

Sponsor: LipimetiX Development, LLC | Conditions: Hypercholesterolemia, Hyperlipoproteinemia Type II | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-12-29